H&H International Holdings released its interim results, with a profit attributable to shareholders of HKD 71.017 million, a year-on-year decrease of 76.78%

According to the Zhitong Finance APP, H&H International Holdings (01112) released its interim results for the six months ending June 30, 2025. The group achieved revenue of RMB 7.019 billion, an increase of 4.89% year-on-year; profit attributable to the parent company was RMB 71.017 million, a decrease of 76.78% year-on-year; basic earnings per share were RMB 0.11. A mid-term dividend of HKD 0.19 per ordinary share is proposed.

The announcement stated that the revenue increase was mainly due to growth in all business segments (i.e., adult nutrition and care products, infant nutrition and care products, and pet nutrition and care products). For the six months ending June 30, 2025, revenue from the group's three business segments of high-margin nutritional supplements grew by 4.6% year-on-year based on comparable benchmarks, accounting for 65.6% of the group's total revenue.

For the six months ending June 30, 2025, revenue from the adult nutrition and care products segment in mainland China achieved strong growth, rising 13.1% compared to the same period last year, accounting for 70.0% of the group's total revenue from adult nutrition and care products. The growth was mainly due to the impressive performance of Swisse's innovative categories that closely align with rapidly changing consumer preferences, particularly in the beauty, anti-aging, and detox categories. The growth was also supported by the group's channel expansion efforts, especially the rapid expansion of online channels, with sales from cross-border e-commerce channels increasing by 18.1%, accounting for 81.5% of the revenue from adult nutrition and care products in mainland China. Revenue from new retail channels such as Sam's Club (covering cross-border e-commerce channels and general trade) increased by 28.2%, accounting for 9.0% of the total revenue from adult nutrition and care products in mainland China. For the 12 months ending June 30, 2025, Swisse continued to maintain its position as the number one brand in the online vitamin, herbal, and mineral supplement market in mainland China and achieved the number one ranking in the overall vitamin, herbal, and mineral supplement market in mainland China.

In the infant nutrition and care products segment in mainland China, for the six months ending June 30, 2025, total revenue increased by 3.8% year-on-year to RMB 2.325 billion. In the infant nutrition and care products segment, revenue from infant formula in mainland China rose by 10.0% year-on-year to RMB 1.905 billion, due to the group's strategic focus on effective consumer education (especially in e-commerce and infant specialty store channels) and expanding market share. In June 2025, Biostime's market share in the ultra-premium infant formula segment in mainland China increased from 12.9% last year to 15.9%, reaching a record high.

For the six months ending June 30, 2025, revenue from the pet nutrition and care products segment in mainland China also resumed growth, rising 17.5% year-on-year to RMB 205 million. The growth was mainly due to Solid Gold's successful restructuring and continued implementation of premiumization, reallocating resources to launch new high-margin pet food and nutritional products. For the six months ending June 30, 2025, these new products accounted for 33.8% of the total revenue from pet nutrition and care products in mainland China